| 000 | 01949cam a2200277zu 4500 | ||
|---|---|---|---|
| 001 | 88964750 | ||
| 003 | FRCYB88964750 | ||
| 005 | 20250429183217.0 | ||
| 006 | m o d | ||
| 007 | cr un | ||
| 008 | 250429s2021 fr | o|||||0|0|||eng d | ||
| 020 | _a9780128205365 | ||
| 035 | _aFRCYB88964750 | ||
| 040 |
_aFR-PaCSA _ben _c _erda |
||
| 100 | 1 | _aBrener, Sorin | |
| 245 | 0 | 1 |
_aDual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease _c['Brener, Sorin'] |
| 264 | 1 |
_bAcademic Press _c2021 |
|
| 300 | _a p. | ||
| 336 |
_btxt _2rdacontent |
||
| 337 |
_bc _2rdamdedia |
||
| 338 |
_bc _2rdacarrier |
||
| 650 | 0 | _a | |
| 700 | 0 | _aBrener, Sorin | |
| 856 | 4 | 0 |
_2Cyberlibris _uhttps://international.scholarvox.com/netsen/book/88964750 _qtext/html _a |
| 520 | _aDual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease is a complete reference containing updated information on the advantages and disadvantages of dual antiplatelet therapy, its duration, composition and anticipated changes. The basis for DAPT in arterial disease is discussed, allowing readers to understand platelet physiology and its relevance to ischemic events. Data on shorter than usual duration of DAPT, and on extended therapy beyond the recommendation of current guidelines is presented in great detail, summarizing a large body of evidence into concrete, relevant recommendation that is readily adaptable by practicing clinicians. A clinically relevant and updated compendium of data pertaining to this field is also presented, as well as the anticipated trends and innovations likely to occur in the next 3-5 years. - Summarizes a large body of evidence into concrete, relevant recommendations that is readily adapted by practicing clinicians - Explores the current status of DAPT, controversial topics, and future developments and trends in this field - Edited and contributed by renowned cardiologists in the field | ||
| 999 |
_c1328787 _d1328787 |
||